3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
155
INDUSTRY
92
NIH
9
NETWORK
7
OTHER_GOV
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Tumor-Agnostic
1
Sarcoma
1
Lymphoid
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Sarcopenia
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Interventions
Pemetrexed
13
Cisplatin
12
Carboplatin
12
Drug Therapy
10
Gemcitabine
8
Gefitinib
8
Docetaxel
8
camrelizumab
5
apatinib
5
Radiotherapy
5
Paclitaxel
5
Nivolumab
5
Irinotecan
5
Erlotinib Hydrochloride
5
Endostatins
5
tislelizumab
4
pembrolizumab
4
endostar protein
4
Simvastatin
4
Bevacizumab
4
anlotinib
3
Platinum Compounds
3
Immune Checkpoint Inhibitors
3
Etoposide
3
toripalimab
2
surufatinib
2
olaparib
2
durvalumab
2
atezolizumab
2
Topotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
durvalumab
×
Thoracic
×
Clear all
NCT03446547
2026-04-14
ASTEROID
Vastra Gotaland Region
Phase 2
Completed
106 enrolled
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled